Corpus Intelligence IC Memo — BELMONT PINES 2026-04-26 17:42 UTC
IC Memo — BELMONT PINES
Investment Committee Memorandum | OH | 53 beds | Grade D | EBITDA uplift $1.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BELMONT PINES

CCN 364038 | MAHONING, OH | 53 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

BELMONT PINES is a 53-bed community hospital in MAHONING, OH with $22.4M in net patient revenue and a 16.8% operating margin. The hospital serves a payer mix of 0.0% Medicare, 0.3% Medicaid, and 99.7% commercial.

Thesis: Turnaround. Our ML models identify $1.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 16.8% to 24.1% (+736bps).

Net Revenue HCRIS$22.4M
Current EBITDA COMPUTED$3.7M
Operating Margin COMPUTED16.8%
Occupancy HCRIS59.0%
Revenue / Bed COMPUTED$422K
Net-to-Gross HCRIS54.5%
Distress Probability MLnan%

2. Market Context & Competitive Position

235
OH Hospitals
-0.3%
State Median Margin
86
Comparable Hospitals

OH has 235 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of 16.8% places it above the state median. Among 86 size-comparable peers (26-106 beds), the median margin is -0.9%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (26-106), prioritizing same-state peers. 86 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BELMONT PINES (Target)OH53$22.4M16.8%
KNOX COMMUNITY HOSPITALOH64$196.0M-16.7%
UH GEAUGA MEDICAL CENTEROH106$183.3M6.9%
CRYSTAL CLINIC ORTHOPAEDIC CENOH59$173.3M-14.9%
OBLENESS MEMORIAL HOSPITALOH67$160.9M29.9%
WOOSTER COMMUNITY HOSPITALOH104$151.3M2.6%
MEMORIAL HOSPITAL OF UNION COUOH51$151.0M8.0%
FISHER-TITUS MEDICAL CENTEROH78$148.3M-6.9%
WESTERN RESERVE HOSPITALOH83$147.6M-9.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$469K+210bp18mo
Cost to Collect4.5%2.5%$447K+200bp12mo
Denial Rate Reduction12.0%6.5%$443K+198bp12mo
A/R Days Reduction5200.0%3800.0%$272K+122bp9mo
Clean Claim Rate88.0%96.0%$14K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$469K
Cost to Collect
$447K
Denial Rate Reduction
$443K
A/R Days Reduction
$272K
Clean Claim Rate
$14K
Total EBITDA Uplift$1.6M
Current EBITDA$3.7M
+ RCM Uplift+$1.6M
Pro Forma EBITDA$5.4M
Current Margin16.8%
Pro Forma Margin24.1%
WC Released (1x)$857K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$5.8M$41.2M7.14x48.2%
Base (11x exit)10.0x11.0x$5.8M$47.1M8.18x52.3%
Bull Case9.0x11.0x$5.2M$54.4M10.50x60.0%
Bull (12x exit)9.0x12.0x$5.2M$60.9M11.75x63.7%
Bear Case11.0x10.0x$6.3M$31.1M4.90x37.4%
Bear (11x exit)11.0x11.0x$6.3M$36.2M5.72x41.7%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 86 hospitals with 26-106 beds
  • Same-state prioritization (n=87)
  • Comp margins: P25=-15.7% / P50=-0.9% / P75=9.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.